Status:
UNKNOWN
Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap.
Lead Sponsor:
Mansoura University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
Brief Summary
Increasing number of breast cancer patients are being treated with conservative surgery; without the need for mastectomy. The cosmetic sequel of breast conservative surgery can be unsatisfactory to th...
Detailed Description
Breast conservative surgery is the standard of care for early breast cancer patients. Large multi-center randomized trials have shown breast conservative surgery to be non-inferior to total mastectomy...
Eligibility Criteria
Inclusion
- Patients with early breast cancer or phylloides tumor.
- Eligible for breast conservative surgery.
- Expected post-lumpectomy volume loss of 20-40% of breast volume.
- Tumor location in upper quadrants.
- Informed consent.
Exclusion
- Patient refusal.
- Contraindication of breast conservative therapy:
- Pregnancy.
- Diffuse microcalcifications.
- Patient choice for mastectomy.
- Collagen / vascular disease.
- Multicentric tumor.
- Psychological co-morbidity.
Key Trial Info
Start Date :
August 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04091958
Start Date
August 24 2019
End Date
February 28 2022
Last Update
November 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Oncology Center
Al Mansurah, DK, Egypt, 35516